{"id":50124,"date":"2025-06-23T13:10:10","date_gmt":"2025-06-23T11:10:10","guid":{"rendered":"https:\/\/www.maiwald.eu\/?post_type=veranstaltungen&#038;p=50124"},"modified":"2025-06-23T13:12:22","modified_gmt":"2025-06-23T11:12:22","slug":"maiwald-platinum-partner-at-the-2025-life-sciences-strategy-summit-on-ip-exclusivity","status":"publish","type":"veranstaltungen","link":"https:\/\/www.maiwald.eu\/jp\/events\/maiwald-platinum-partner-at-the-2025-life-sciences-strategy-summit-on-ip-exclusivity\/","title":{"rendered":"Maiwald Platinum Partner at the 2025 Life Sciences Strategy Summit on IP &amp; Exclusivity"},"content":{"rendered":"\n<p>We are pleased to announce that Maiwald Intellectual Property will participate as a <strong>Platinum Partner<\/strong> at the upcoming <strong>Life Sciences Strategy Summit on IP &amp; Exclusivity<\/strong>, taking place in the Infinity Hotel &amp; Conference Resort Munich<strong> <\/strong>from<strong> 13\u201315 October 2025<\/strong>.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.maiwald.eu\/jp\/team\/eva-ehlich\/\" data-type=\"link\" data-id=\"https:\/\/www.maiwald.eu\/en\/team\/eva-ehlich\/\">Dr. Eva Ehlich<\/a>, Partner at Maiwald, will serve as Event Co-Chair and Panel Chair.<br>She will lead a key session on <strong>Antibody Exclusivity Challenges Considering the Post-G2\/21 and Amgen vs Sanofi Landscape<\/strong><\/p>\n\n\n\n<p>The session will address:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The role of \u201csurprising technical effect\u201d in antibody patents<\/li>\n\n\n\n<li>Impact of G2\/21 on inventive step analysis<\/li>\n\n\n\n<li>Legal implications of the Amgen vs Sanofi decision<\/li>\n\n\n\n<li>IP and ownership challenges in antibody-drug conjugates (ADCs)<\/li>\n\n\n\n<li>New approaches to defining the objective technical problem in antibody cases<\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/www.maiwald.eu\/jp\/team\/eva-ehlich\/\" data-type=\"link\" data-id=\"https:\/\/www.maiwald.eu\/en\/team\/eva-ehlich\/\">Dr. Ehlich<\/a> will be joined by senior legal and scientific representatives from Novartis, Amgen, and Sterne, Kessler, Goldstein &amp; Fox.<\/p>\n\n\n\n<p>In addition, <a href=\"https:\/\/www.maiwald.eu\/jp\/team\/anja-fux\/\" data-type=\"link\" data-id=\"https:\/\/www.maiwald.eu\/en\/team\/anja-fux\/\">Dr. Anja Fux<\/a> will chair a session on <strong>EPO Board of Appeal Cases and the Effect Upon the Life Sciences Sector<\/strong> (Cases: G1\/24, G2\/21, T 1977\/22, G1\/23)<\/p>\n\n\n\n<p>Discussion points include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The implications of G1\/24 and G1\/23 for the scope and enforceability of life sciences patents<\/li>\n\n\n\n<li>The evolving plausibility standard following G2\/21<\/li>\n\n\n\n<li>T 1977\/22 and its relevance to open-range sufficiency<\/li>\n<\/ul>\n\n\n\n<p>With over 400 participants expected, including in-house counsel and legal experts from originator, generic, and biotech companies, the summit provides a key platform for discussion and strategic exchange at the interface of law, science, and innovation.<\/p>\n\n\n\n<p>More information and the full agenda are available <a href=\"https:\/\/share.hsforms.com\/1Um-l2XccRC6Jm8DxOoPouw5ct5e?utm_campaign=176.4%20Life%20Science%20Strategy%20Summit%20on%20IP%20%26%20Exclusivity&amp;utm_content=335674887&amp;utm_medium=social&amp;utm_source=linkedin&amp;hss_channel=lcp-76104580\" data-type=\"link\" data-id=\"https:\/\/share.hsforms.com\/1Um-l2XccRC6Jm8DxOoPouw5ct5e?utm_campaign=176.4%20Life%20Science%20Strategy%20Summit%20on%20IP%20%26%20Exclusivity&amp;utm_content=335674887&amp;utm_medium=social&amp;utm_source=linkedin&amp;hss_channel=lcp-76104580\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n","protected":false},"featured_media":50129,"template":"","meta":{"_acf_changed":false,"footnotes":""},"veranstaltungstyp":[],"class_list":["post-50124","veranstaltungen","type-veranstaltungen","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/veranstaltungen\/50124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/veranstaltungen"}],"about":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/types\/veranstaltungen"}],"version-history":[{"count":1,"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/veranstaltungen\/50124\/revisions"}],"predecessor-version":[{"id":50133,"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/veranstaltungen\/50124\/revisions\/50133"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/media\/50129"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/media?parent=50124"}],"wp:term":[{"taxonomy":"veranstaltungstyp","embeddable":true,"href":"https:\/\/www.maiwald.eu\/jp\/wp-json\/wp\/v2\/veranstaltungstyp?post=50124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}